Lisata Therapeutics (LSTA) Return on Invested Capital (2016 - 2025)
Historic Return on Invested Capital for Lisata Therapeutics (LSTA) over the last 11 years, with Q3 2025 value amounting to 0.99%.
- Lisata Therapeutics' Return on Invested Capital fell 3600.0% to 0.99% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.99%, marking a year-over-year decrease of 3600.0%. This contributed to the annual value of 0.55% for FY2024, which is N/A changed from last year.
- As of Q3 2025, Lisata Therapeutics' Return on Invested Capital stood at 0.99%, which was down 3600.0% from 0.86% recorded in Q2 2025.
- Lisata Therapeutics' Return on Invested Capital's 5-year high stood at 0.36% during Q2 2023, with a 5-year trough of 0.99% in Q3 2025.
- Moreover, its 3-year median value for Return on Invested Capital was 0.6% (2024), whereas its average is 0.62%.
- Per our database at Business Quant, Lisata Therapeutics' Return on Invested Capital tumbled by -2100bps in 2024 and then plummeted by -3600bps in 2025.
- Lisata Therapeutics' Return on Invested Capital (Quarter) stood at 0.46% in 2023, then crashed by -49bps to 0.68% in 2024, then tumbled by -46bps to 0.99% in 2025.
- Its Return on Invested Capital was 0.99% in Q3 2025, compared to 0.86% in Q2 2025 and 0.75% in Q1 2025.